Home
About
Overview
Sharing Data
ORCID
Help
History (90)
Prophylactic cranial irradiation in small-cell lung cancer.
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer.
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours.
Designing food structure and composition to enhance nutraceutical bioactivity to support cancer inhibition.
Reviewing concomitant medications for participants in oncology clinical trials.
See All 90 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reviewing concomitant medications for participants in oncology clinical trials.
McGahey KE, Weiss GJ. Reviewing concomitant medications for participants in oncology clinical trials. Am J Health Syst Pharm. 2017 Apr 15; 74(8):580-586.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Clinical Trials as Topic
Drug Interactions
Drugs, Investigational
Humans
Neoplasms
Practice Guidelines as Topic
authors with profiles
Glen Weiss MD, MBA